BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 8008210)

  • 1. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system.
    De Vos H; Bricca G; De Keyser J; De Backer JP; Bousquet P; Vauquelin G
    Neuroscience; 1994 Apr; 59(3):589-98. PubMed ID: 8008210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine.
    King PR; Gundlach AL; Louis WJ
    Brain Res; 1995 Mar; 675(1-2):264-78. PubMed ID: 7796138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A; Widdowson PS; Cordi A
    Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and autoradiographical localization of non-adrenoceptor idazoxan binding sites in the rat brain.
    Mallard NJ; Hudson AL; Nutt DJ
    Br J Pharmacol; 1992 Aug; 106(4):1019-27. PubMed ID: 1356565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic comparison of [3H]-clonidine binding to non-adrenergic sites and alpha(2)-adrenergic receptors in human brain.
    Piletz JE; Ordway GA; Zhu H; Duncan BJ; Halaris A
    Neuropsychopharmacology; 2000 Dec; 23(6):697-708. PubMed ID: 11063925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human I1 receptors and their relationship to alpha 2-adrenoceptors.
    Dontenwill M; Vonthron C; Greney H; Magnier C; Heemskerk F; Bousquet P
    Ann N Y Acad Sci; 1999 Jun; 881():123-34. PubMed ID: 10415908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic distribution of alpha 2 adrenoceptors, NAIBS, and 5-HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscine.
    De Vos H; Convents A; De Keyser J; De Backer JP; Van Megen IJ; Ebinger G; Vauquelin G
    Brain Res; 1991 Dec; 566(1-2):13-20. PubMed ID: 1667606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of [3H]idazoxan, [3H]RX821002 and p-[125I]iodoclonidine binding to alpha 2-adrenoceptors in rat cerebral cortical membranes.
    Wallace DR; Muskardin DT; Zahniser NR
    Eur J Pharmacol; 1994 Jun; 258(1-2):67-76. PubMed ID: 7925601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of binding sites for [3H]-idazoxan, [3H]-P-aminoclonidine and [3H]-rauwolscine in the kidney of the dog.
    Evans RG; Haynes JM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):649-58. PubMed ID: 7813124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues.
    Molderings GJ; Likungu J; Jakschik J; Göthert M
    Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
    Zonnenchein R; Diamant S; Atlas D
    Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of I2-imidazoline sites in rat prostate. Effect of castration and aging.
    Regunathan S; Nassir Y; Sundaram K; Vaughan ED; Reis DJ; Felsen D
    Biochem Pharmacol; 1996 Feb; 51(4):455-9. PubMed ID: 8619890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of alpha 2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells.
    Senard JM; Langin D; Estan L; Paris H
    Eur J Pharmacol; 1990 Nov; 191(1):59-68. PubMed ID: 1982658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortex.
    Bricca G; Greney H; Dontenwill-Kieffer M; Zhang J; Belcourt A; Bousquet P
    Neurochem Int; 1993 Feb; 22(2):153-63. PubMed ID: 8439769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazoline-guanidinium and alpha 2-adrenergic binding sites in basolateral membranes from human kidney.
    Lachaud-Pettiti V; Podevin RA; Chrétien Y; Parini A
    Eur J Pharmacol; 1991 Jan; 206(1):23-31. PubMed ID: 1648494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.